Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine

The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) project designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia, identified three drug mechanisms of particular interest: dopaminergic, cholinerg...

Ausführliche Beschreibung

Bibliografische Detailangaben

1. Verfasser:	Maju Mathew Koola
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2016-06-01
Schriftenreihe:	Schizophrenia Research: Cognition
Schlagworte:	Schizophrenia Cognitive impairments Kynurenine pathway Pharmacogenetics α-7 nicotinic receptor and NMDA receptor
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S221500131630004X
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!